ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Aurobindo Pharma Limited Complete list of announcements declared & dividend announcements by Aurobindo Pharma Limited AUROPHARMA

Aurobindo Pharma Limited AUROPHARMA listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Aurobindo Pharma Limited AUROPHARMA

Company Announcement
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 22, 2026, titled "Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company".
Announcement as on 22 June 2026

Company Announcement
Aurobindo Pharma Limited has informed the Exchange about General Updates
Announcement as on 22 June 2026

Aurobindo Pharma US gets FTC nod for 0 million acquisition of Lannett Company
Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its 0 million acquisition of Lannett Company. This strategic move, expected to conclude by June 2026, will bolster Aurobindo's complex generics and controlled substances portfol
Announcement as on 22 June 2026

Company Announcement
Aurobindo Pharma Limited has informed that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today.
Announcement as on 19 June 2026

Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of Lannett Company. This regulatory approval removes the final hurdle. The acquis
Announcement as on 19 June 2026

Announcements by Aurobindo Pharma Limited first page | Next page | Prev page |

AUROPHARMA Aurobindo Pharma Limited current price & indicator signals

Moving Averages for Aurobindo Pharma Limited

  • 5Day Average: 1559
  • 12Day Average: 1509.36
  • 20Day Average: 1486.89
  • 50Day Average: 1467.94
  • 100Day Average: 1362.11
  • 150Day Average: 1305.01
  • 200Day Average: 1259.46

AUROPHARMA Indicators & signals

Indicator MACD (12,26,9)

1523.86, 1493.29, 20.57
Indicator MACD is in positive zone

Indicator ADX (14)

37.12, 27.52, 12.62
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Jul 2026 1561.00 1545.00 to 1566.90 0.54% 0.32 times
01 Wed Jul 2026 1552.60 1549.70 to 1588.70 -1.65% 0.3 times
30 Tue Jun 2026 1578.70 1547.50 to 1588.90 2.02% 1.62 times
29 Mon Jun 2026 1547.50 1538.10 to 1585.30 -0.5% 2.32 times
25 Thu Jun 2026 1555.20 1532.00 to 1565.00 1.61% 1.05 times
24 Wed Jun 2026 1530.60 1525.20 to 1550.90 -0.23% 0.54 times
23 Tue Jun 2026 1534.20 1492.20 to 1542.70 2.84% 1.05 times
22 Mon Jun 2026 1491.90 1476.50 to 1511.00 -0.39% 0.86 times
19 Fri Jun 2026 1497.80 1446.40 to 1503.10 3.75% 1.25 times
18 Thu Jun 2026 1443.70 1416.10 to 1447.70 1.5% 0.47 times
17 Wed Jun 2026 1422.40 1400.00 to 1434.10 1.84% 0.55 times
16 Tue Jun 2026 1396.70 1391.30 to 1410.00 -0.82% 0.56 times

Videos related to: AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

 

Back to top